Free tool
FAERS Monitor: Northera
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 203202 or its brand name (Northera, Droxidopa). Reports on generic versions are filed under their own applications.
Reports
21,553
Serious
8,359
39% of reports
Hospitalization
3,413
Death reported
2,843
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- dizziness2,924
- death2,201
- blood pressure increased1,886
- drug ineffective1,674
- headache1,589
- fall1,521
- hypotension1,268
- fatigue1,203
- hypertension1,153
- nausea1,070
- blood pressure decreased1,016
- drug dose omission958
- loss of consciousness855
- malaise848
- blood pressure fluctuation768
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 6 |
| 2005 | 4 |
| 2006 | 8 |
| 2007 | 5 |
| 2008 | 5 |
| 2009 | 6 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 15 |
| 2013 | 6 |
| 2014 | 169 |
| 2015 | 2,362 |
| 2016 | 3,714 |
| 2017 | 4,065 |
| 2018 | 3,508 |
| 2019 | 2,034 |
| 2020 | 2,274 |
| 2021 | 1,495 |
| 2022 | 453 |
| 2023 | 422 |
| 2024 | 365 |
| 2025 | 359 |
| 2026 | 272 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,032,606 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| blood pressure fluctuationSignal | 768 | 32.2 | 30.0 | 22,489 |
| blood pressure decreasedSignal | 1,016 | 15.1 | 14.2 | 13,237 |
| blood pressure increasedSignal | 1,886 | 12.2 | 11.7 | 19,237 |
| loss of consciousnessSignal | 855 | 6.5 | 6.1 | 4,013 |
| hypotensionSignal | 1,268 | 6.2 | 5.9 | 5,545 |
| dizzinessSignal | 2,924 | 5.7 | 5.6 | 11,675 |
| drug dose omissionSignal | 958 | 5.7 | 5.3 | 3,699 |
| hypertensionSignal | 1,153 | 5.3 | 5.0 | 4,077 |
| fallSignal | 1,521 | 4.5 | 4.3 | 4,149 |
| deathSignal | 2,201 | 2.5 | 2.4 | 2,053 |
| headacheSignal | 1,589 | 2.5 | 2.4 | 1,437 |
| malaise | 848 | 1.9 | 1.8 | 360 |
| fatigue | 1,203 | 1.5 | 1.4 | 213 |
| nausea | 1,070 | 1.3 | 1.2 | 86 |
| drug ineffective | 1,674 | 1.2 | 1.2 | 82 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.